Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)

Institutions:

• The Netherlands Cancer Institute, Amsterdam
• Dana-Farber Cancer Institute, Boston, Massachusetts
• Institute of Pathology, University of Würzburg, Würzburg
• British Columbia Cancer Agency, University of British Columbia, Vancouver
• Department of Pathology, Inserm U617, Hôpital Henri Mondor, Créteil
• Department of Pathology, Hematopathology Section, University Hospital Schleswig-Holstein, Campus Kiel
• CRUK Medical Oncology Unit, St Bartholomew’s Hospital, London
• Karolinska Institutet, Stockholm
• University Clinic Schleswig-Holstein, Campus Lübeck
• Hospital Clinic, University of Barcelona, Barcelona
• Université Paris-Descartes
• AP-HP, Hôtel-Dieu, Paris
• Academic Medical Center, Amsterdam
• Stanford University Medical Center, Palo Alto, California
• St Bartholomew’s Hospital, Department of Medical Oncology, London
• University Medical Center Nijmegen
• Hospices Civils de Lyon and Université Claude Bernard Lyon-1, Lyon